Despite the developments in the diagnostic and man agement strategies, a considerable number of colo rectal cancer (CRC) patients present with disease recurrence after curative surgery. Moreover; there are no reliable indicators to determine the prognosis and response of CRC patients to therapy. By har nessing recent technological advances in molecular profiling techniques, it is anticipated that greater in sight to the various combinations of genetic events or alternative pathways underlying carcinogenesis will be gained. By carrying out literature search, we were able to identify a comprehensive list of genes with high differential expression patterns in colorectal can cer that could serve as molecular markers to com plement existing histopathological factors in diagnosis, follow up and therapeutic strategies for individualized care of patients.
KeywordsMolecular Profiling in Colorectal CancerGene Expression in Colorectal CancerColorectal Cancer GeneticsColorectal Cancer
Forrester, K., Almoguera, C., Han, K., et al. (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature, 327, 298-303. doi:10.1038/327298a0
Ionov, Y., Peinado, M.A., Malkhosyan, S., et al. (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363, 558-561. doi:10.1038/363558a0
Cui, H., Horon, I.L., Ohlsson, R., et al. (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Medicine, 4, 1276-1280. doi:10.1038/3260
Vogelstein, B., Fearon, E.R., Hamilton, S.R., et al. (1988) Genetic alterations during colorectal-tumor development. New England Journal of Medicine, 319, 525-532. doi:10.1056/NEJM198809013190901
Kitahara, O., Furukawa, Y., Tanaka, T., et al. (2001) Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Research, 61, 3544-3549.
Lin, Y.M., Furukawa, Y., Tsunoda, T., et al. (2002) Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene, 21, 4120-4128. doi:10.1038/sj.onc.1205518
Zou, T.T., Selaru, F.M., Xu, Y., et al. (2002) Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene, 21, 4855-4862. doi:10.1038/sj.onc.1205613
Kwon, H.C., Kim, S.H., Roh, M.S., et al. (2004) Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Diseases of the Colon & Rectum, 47, 141-152. doi:10.1007/s10350-003-0032-7
Friederichs, J., Rosenberg, R., Mages, J., et al. (2005) Gene expression profiles of different clinical stages of colorectal carcinoma: Toward a molecular genetic understanding of tumor progression. International Journal of Colorectal Disease, 20, 391-402. doi:10.1007/s00384-004-0722-1
Kim, K., Park, U., Wang, J., et al. (2008) Gene profiling of colonic serrated adenomas by using oligonucleotide microarray. International Journal of Colorectal Disease, 23, 569-580. doi:10.1007/s00384-008-0451-y
Kita, H., Hikichi, Y., Hikami, K., et al. (2006) Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. Journal of Gastroenterology, 41, 1053-1063. doi:10.1007/s00535-006-1894-y
Agrawal, D., Chen, T.G., Irby, R., et al. (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. Journal of the National Cancer Institute, 94, 513-521. doi:10.1093/jnci/94.7.513
Koehler, A., Bataille, F., Schmid, C., et al. (2004) Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. Journal of Pathology, 204, 65-74. doi:10.1002/path.1606
Yanagawa, R., Furukawa Y., Tsunoda T., et al. (2001) Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia, 3, 395-401. doi:10.1038/sj.neo.7900185
Ki, D.H., Jeung, H.C., Park, C.H., et al. (2007) Whole genome analysis for liver metastasis gene signatures in colorectal cancer. International Journal of Cancer, 121, 2005-2012. doi:10.1002/ijc.22975
Lin, H.M., Chatterjee, A., Lin, Y.H., et al. (2007) Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncology Reports, 17, 1541-1549
Watanabe, T., Kobunai, T., Tanaka, T., et al. (2009) Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray. Diseases of the Colon & Rectum, 52, 1941-1948. doi:10.1007/DCR.0b013e3181b53684
Wang, Y., Jatkoe, T., Zhang, Y., et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. Journal of Clinical Oncology, 22, 1564-1571. doi:10.1200/JCO.2004.08.186
Birkenkamp-Demtroder, K., Olesen, S.H., Sorensen, F.B. et al. (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut, 54, 374-384. doi:10.1136/gut.2003.036848
Ghadimi, B.M., Grade, M., Difilippantonio, M.J., et al. (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. Journal of Clinical Oncology, 23, 1826-1838. doi:10.1200/JCO.2005.00.406
Kim, I.J., Lim, S.B., Kang, H.C., et al. (2007) Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Diseases of the Colon & Rectum, 50, 1342-1353. doi:10.1007/s10350-007-277-7
Mariadason, J.M., Arango, D., Shi, Q.H., et al. (2003) Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Research, 63, 8791-8812
Del Rio, M., Molina, F., Mollevi, C.B., et al. (2007) Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. Journal of Clinical Oncology, 25, 773-780. doi:10.1200/JCO.2006.07.4187
Khambata-Ford, S., Garrett C.R., Meropol N.J., et al. (2007) Expression of epiregulin and amphiregulin and Kras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology, 25, 3230-3237. doi:10.1200/JCO.2006.10.5437
Kim, I.J., Lim, S.B., Kang, H.C., et al. (2007) Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Diseases of the Colon & Rectum, 50, 1342-1353. doi:10.1007/s10350-007-277-7
Rimkus, C., Friederichs, J., Boulesteix, A.L., et al. (2008) Microarray-based prediction of tumor response to neoadjuvant radiochernotherapy of patients with locally advanced rectal cancer. Clinical Gastroenterology and Hepatology, 6, 53-61. doi:10.1016/j.cgh.2007.10.022
Spitzner, M., Emons, G., Kramer, F., et al. (2010) A gene expression signature for chemoradiosensitivity of colorectal cancer cells. International Journal of Radiation Oncology, Biology, Physics, 78, 1184-1192. doi:10.1016/j.ijrobp.2010.06.023
Cunningham, D., Humblet, Y., Siena, S., et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. New England Journal of Medicine, 351, 337-345. doi:10.1056/NEJMoa033025
Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine, 350, 2335-2342. doi:10.1056/NEJMoa032691
Mayer, R.J. (2009) Targeted therapy for advanced colorectal cancer-more is not always better. New England Journal of Medicine, 360, 623-625. doi:10.1056/NEJMe0809343
Saltz, L.B., Meropol, N.J., Loehrer, P.J. et al. (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. Journal of Clinical Oncology, 22, 1201-1208. doi:10.1200/JCO.2004.10.182
Waldner, M.J. and Neurath, M.F. (2010) The molecular therapy of colorectal cancer. Molecular Aspects of Medicine, 31, 171-178. doi:10.1016/j.mam.2010.02.005
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C-elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 75, 843-854. doi:10.1016/0092-8674(93)90529-Y
Brennecke, J., Hipfner, D.R. and Stark, A. et al. (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36. doi:10.1016/S0092-8674(03)00231-9
Lagos-Quintana, M., Rauhut, R., Yalcin, A. et al. (2002) Identification of tissue-specific microRNAs from mouse. Current Biology, 12, 735-739. doi:10.1016/S0960-9822(02)00809-6
Calin, G.A., Dumitru, C.D., Shimizu, M. et al. (2002) Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 99, 15524-15529. doi:10.1073/pnas.242606799
Michael, M.Z., O’Connor, S.M., Pellekaan, N.G.V., et al. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Molecular Cancer Research, 1, 882-891.
Schetter, A.J., Leung, S.Y., Sohn, J.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama-Journal of the American Medical Association, 299, 425-436. doi:10.1001/jama.299.4.425
Akao, Y., Nakagawa, Y. and Naoe T. (2007) MicroRNA-143 and-145 in colon cancer. DNA and Cell Biology, 26, 311-320. doi:10.1089/dna.2006.0550
Braun, C.J., Zhang, X., Savelyeva, I., et al. (2008) P53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Research, 68, 10094-10104. doi:10.1158/0008-5472.CAN-08-1569
He, X.Y., He, L. and Hannon, G.J. (2007) The guardian’s little helper: MicroRNAs in the p53 tumor suppressor network. Cancer Research, 67, 11099-11101. doi:10.1158/0008-5472.CAN-07-2672
Wang, P., Zou, F., Zhang, X. et al. (2009) MicroRNA-21 negatively regulates cdc25A and cell cycle progression in colon cancer cells. Cancer Research, 69, 8157-8165. doi:10.1158/0008-5472.CAN-09-1996
Asangani, I.A., Rasheed, S.A.K., Nikolova, D.A. et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136. doi:10.1038/sj.onc.1210856
Nagel, R., Le Sage, C., Diosdado, B. et al. (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Research, 68, 5795-5802. doi:10.1158/0008-5472.CAN-08-0951
Guo, C.G., Sah, J.F., Beard, L., et al. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes & Cancer, 47, 939-946. doi:10.1002/gcc.20596
Bandres, E., Cubedo, E., Agirre, X., et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and nontumoral tissues. Molecular Cancer, 5, 29.
Xi Y., Formentini, A., Chien, M., et al. (2006) Prognostic values of microRNAs in colorectal cancer. Biomark Insights, 2, 113-121.
Arndt, G.M., Dossey, L., Cullen, L.M. et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer, 9, 374.
Motoyama, K., Inoue, H., Takatsuno, Y., et al. (2009) Over-and under-expressed microRNAs in human colorectal cancer. International Journal of Oncology, 34, 1069-1075.
Wang, C.J., Zhou, Z.G., Wang, L. et al. (2009) Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Disease Markers, 26, 27-34.
Lanza, G., Ferracin, M., Gafa, R. et al. (2007) MRNA/ microRNA gene expression profile in microsatellite unstable colorectal cancer. Molecular Cancer, 6, 54.
Kloosterman, W.P., Lagendijk, A.K., Ketting, R.F. et al. (2007) Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. Plos Biology, 5, 1738-1749. doi:10.1371/journal.pbio.0050203
Hutvagner, G. and Zamore P.D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060. doi:10.1126/science.1073827
Elmen, J., Lindow, M., Silahtaroglu, A. et al. (2008) Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research, 36, 1153-1162. doi:10.1093/nar/gkm1113
Krutzfeldt, J., Rajewsky, N., Braich, R. et al. (2005) Silencing of microRNAs in vivo with “antagomirs”. Nature, 438, 685-689. doi:10.1038/nature04303
Brosens, L.A.A., Van Hattem, W.A., Jansen, M. et al. (2007) Gastrointestinal polyposis syndromes. Current Molecular Medicine, 7, 29-46. doi:10.2174/156652407779940404
Lu, Z., Liu, M., Stribinskis, V. et al. (2008) MicroRNA21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 27, 4373-4379. doi:10.1038/onc.2008.72
Dews, M., Homayouni, A., Yu, D. et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated micro-RNA cluster. Nature Genet, 38, 1060-1065. doi:10.1038/ng1855
Rossi, L., Bonmassar, E. and Faraoni, I. (2007) Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacological Research, 56, 248-253. doi:10.1016/j.phrs.2007.07.001
Meng, F.Y., Henson, R., Lang, M. et al. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 130, 2113-2129. doi:10.1053/j.gastro.2006.02.057